Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer

• Chia-Yi Su,

  Affiliation Genomics Research Center, Academia Sinica, Taipei, Taiwan

  ⨯
• Yu-Peng Liu,

  Affiliation Department of Genome Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Chih-Jen Yang,

  Affiliation Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Yuan-Feng Lin,

  Affiliation Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Jean Chiou,

  Affiliations Genomics Research Center, Academia Sinica, Taipei, Taiwan, The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan

  ⨯
• Li-Hsing Chi,

  Affiliation The Ph.D. Program for Translational Medicine, Taipei Medical University and Academia Sinica, Taipei, Taiwan

  ⨯
• Jih-Jong Lee,

  Affiliation Institute of Veterinary Clinical Science, School of Veterinary Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Alex T. H. Wu,

  Affiliation The Ph.D. Program for Translational Medicine, Taipei Medical University and Academia Sinica, Taipei, Taiwan

  ⨯
• Pei-Jung Lu,

  Affiliation Institute of Clinical Medicine, National Cheng-Kung University, Tainan, Taiwan

  ⨯
• Ming-Shyan Huang ,

  * E-mail: mhsiao@gate.sinica.edu.tw (MH); shyang@kmu.edu.tw (MSH)

  Affiliation Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Michael Hsiao

  * E-mail: mhsiao@gate.sinica.edu.tw (MH); shyang@kmu.edu.tw (MSH)

  Affiliation Genomics Research Center, Academia Sinica, Taipei, Taiwan

  ⨯